Vizient Bolsters IV Fluid Supply Chain with Fresenius Kabi Partnership

  • Vizient adds Fresenius Kabi to its Reserve Program to expand supply assurance for 13 critical IV fluid products.
  • Dedicated U.S.-based inventory and contingency manufacturing plans are now part of the program.
  • Fresenius Kabi brings global healthcare expertise to Vizient's supply continuity efforts.
  • The collaboration aims to mitigate supply disruptions for participating healthcare organizations.

Vizient's move to strengthen its supply chain for critical IV fluids comes amid ongoing challenges in healthcare supply continuity. The partnership with Fresenius Kabi reflects a broader industry trend toward proactive supply assurance strategies, particularly for lifesaving medicines and medical technologies. With more than two-thirds of U.S. acute care providers relying on Vizient, this collaboration could set a new standard for managing supply chain risks in the healthcare sector.

Supply Chain Stability
How the addition of Fresenius Kabi will affect Vizient's ability to manage future supply disruptions.
Market Expansion
Whether this partnership will lead to broader collaborations with other medical supply providers.
Operational Efficiency
The pace at which Vizient can integrate Fresenius Kabi's inventory and manufacturing capabilities into its existing framework.